Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Apr 11. Online ahead of print. doi: 10.1016/j.jtha.2023.02.033

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 The Authors

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Platelet activation markers and prothrombotic factors of the study cohorts. (A) FVIII, (B) VWF, (C) sP-selectin, and (D) PF4 levels of non-COVID (n = 54, in FVIII graph n = 53), mild/moderate COVID-19 (n = 52), severe/critical COVID-19 (n = 74), convalescents (n = 66) subjects. (E) MPO levels in non-COVID (n = 52), mild/moderate COVID-19 (n = 47), severe/critical COVID-19 (n = 71), convalescent cohorts (n = 65). (F) cfDNA levels in non-COVID (n = 50), mild/moderate COVID-19 (n = 47), severe/critical COVID-19 (n = 70), convalescent cohorts (n = 65). (G) MPO-DNA complex levels in non-COVID (n = 42), mild/moderate COVID-19 (n = 32), severe/critical COVID-19 (n = 59), and convalescents (n = 61). (H) NETosis induction levels in non-COVID (n = 54), mild/moderate COVID-19 (n = 48), severe/critical COVID-19 (n = 73), convalescents (n = 66).